<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29380" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Splenic Infarcts</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chapman</surname>
            <given-names>Jennifer</given-names>
          </name>
          <aff>Lahey Health Systems</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Helm</surname>
            <given-names>Travis A.</given-names>
          </name>
          <aff>Kaweah Delta</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kahwaji</surname>
            <given-names>Chadi I.</given-names>
          </name>
          <aff>Universtity of California, Irvine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jennifer Chapman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Travis Helm declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chadi Kahwaji declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29380.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Splenic infarction occurs when the blood supply to the spleen is compromised, resulting in tissue ischemia and eventual necrosis. It may be the result of arterial or venous occlusion. The infarction may be global or involve a small segmental area of the spleen, depending on which vessel is occluded. Typical presentation includes left-sided abdominal pain in a person with an underlying hematologic disorder, hypercoagulable state, blood-borne malignancy, blunt abdominal trauma, or embolic illness. This activity reviews the role of the interprofessional team in the evaluation and treatment of splenic infarction and how the collective effort can improve patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline the presentation of a patient with a splenic infarct.</p></list-item><list-item><p>Describe the pathophysiology of splenic infarction.</p></list-item><list-item><p>Summarize the treatment options for splenic infarction.</p></list-item><list-item><p>Identify the value of improving care coordination among the interprofessional team to ensure that patients with splenic infarction get vaccinated against encapsulated organisms, which can enhance outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29380&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29380">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29380.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The spleen is a hematopoietic organ that filters and removes aging blood products and aids in immunity against encapsulated bacterial organisms. Splenic infarction occurs when blood flow to the spleen is compromised, causing tissue ischemia and eventual necrosis. Splenic infarction may be the result of arterial or venous occlusion.&#x000a0;Occlusion is&#x000a0;usually caused by bland or septic emboli as well as venous congestion by abnormal cells. Infarction may involve a small segmental area of the spleen or may be global, depending on which vessel is occluded. This occurrence is caused by a wide variety of underlying disease states with prognosis dependent on the causative illness.&#x000a0;The most typical presentation includes left sided abdominal pain in a patient with underlying hematologic disorder, blood borne malignancy, blunt abdominal trauma, hypercoagulable state, or embolic illness. Treatment of splenic infarction ranges from supportive care to splenectomy.&#x000a0;<xref ref-type="bibr" rid="article-29380.r1">[1]</xref><xref ref-type="bibr" rid="article-29380.r2">[2]</xref><xref ref-type="bibr" rid="article-29380.r3">[3]</xref></p>
        <p>Therapeutic splenic infarction via splenic embolization has been used to treat hemorrhage from traumatic splenic injuries. Splenic embolization has also been used in the treatment of severe portal hypertension and in the pre-operative phase of splenectomy to reduce intra-operative blood loss.</p>
      </sec>
      <sec id="article-29380.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The two most common causes of splenic infarction are thromboembolic disease and infiltrative hematologic diseases. In patients under 40 years of age, the most common cause is a hematologic disease. <xref ref-type="bibr" rid="article-29380.r4">[4]</xref>Causes of splenic infarction may be categorized as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>blood-borne malignancy (leukemia, lymphoma), myelofibrosis</p>
          </list-item>
          <list-item>
            <p>hypercoagulable states (sickle cell disease, protein C and S, polycythemia vera, lupus anticoagulant, exogenous estrogen use, malignancy)</p>
          </list-item>
          <list-item>
            <p>thromboembolic disorders (atrial fibrillation, endocarditis, patent foramen ovale, prosthetic heart valves)</p>
          </list-item>
          <list-item>
            <p>blunt abdominal trauma</p>
          </list-item>
          <list-item>
            <p>pancreatic disorders (pancreatitis, compressive pancreatic masses)</p>
          </list-item>
        </list>
        <p>Additionally, broad categories of autoimmune and collagen vascular diseases, as well as the "wandering spleen," have been noted in case reports of splenic infarcts.&#x000a0;</p>
      </sec>
      <sec id="article-29380.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Splenic infarcts are considered a rare cause of abdominal pain, although the exact prevalence is unclear. The diagnosis of splenic infarct is thought to be rising due to increased abdominal imaging, increased use of splenic&#x000a0;embolization, and increased nonoperative management of&#x000a0;traumatic splenic injuries.&#x000a0;This disease may affect patients of all ages. Patients 40 years of age and younger are more likely to have underlying hematologic illness, while patients 40 years of age and older are more likely to suffer splenic infarction due to thromboembolic diseases.<xref ref-type="bibr" rid="article-29380.r5">[5]</xref></p>
      </sec>
      <sec id="article-29380.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The splenic artery (branching off the celiac artery) supplies blood flow to the spleen in combination with the short gastric arteries (branches off of the left gastroepiploic artery).</p>
        <p>One of the most common causes of splenic infarction is sickle hemoglobinopathies.&#x000a0;In patients with sickle cell disease, episodes of hypoxia or acidosis cause red blood cells to transform into an abnormal&#x000a0;shape, leading to crystallization and occlusion of the vasculature.&#x000a0;This process&#x000a0;can lead to multiple infarctions beginning in childhood. Over time, multiple infarctions cause scarring and contraction of the spleen. This may&#x000a0;ultimately result in complete splenic autoinfarction by the time of adulthood.</p>
        <p>Diseases that cause splenomegaly may place patients at risk for splenic infarction. These diseases include chronic myelogenous leukemia, myelofibrosis, Gaucher disease, malarial splenomegaly syndrome, AIDS with <italic toggle="yes">Mycobacterium avium </italic>complex, and lymphoma.</p>
        <p>Rarely, abnormal splenic vascular anatomy may cause infarction. An&#x000a0;anatomical variant known as the wandering spleen&#x000a0;has been identified in which the spleen has an abnormal vascular attachment that predisposes to torsion.</p>
      </sec>
      <sec id="article-29380.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Splenic infarction is a rare cause of abdominal pain. Diagnosis is often suspected based on the presence of underlying disease states most likely to cause splenic infarction. A study published in 2010&#x000a0;set out to better characterize&#x000a0;the&#x000a0;modern experience of splenic infarction.&#x000a0;This study&#x000a0;performed&#x000a0;chart reviews of 26&#x000a0;patients admitted to the hospital with the diagnosis of splenic infarction.&#x000a0;Their observations were as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Mean age 52 years</p>
          </list-item>
          <list-item>
            <p>50% complained of localized left sided abdominal pain</p>
          </list-item>
          <list-item>
            <p>36% had left sided abdominal tenderness</p>
          </list-item>
          <list-item>
            <p>32% splenomegaly</p>
          </list-item>
          <list-item>
            <p>31%&#x000a0;had no&#x000a0;signs or symptoms&#x000a0;localized to the spleen area</p>
          </list-item>
          <list-item>
            <p>36% had a fever temperature greater than 38 &#x000b0;C</p>
          </list-item>
          <list-item>
            <p>56% had WBC &#x0003e;12,000</p>
          </list-item>
          <list-item>
            <p>71% had elevated LDH level</p>
          </list-item>
          <list-item>
            <p>32% had nausea and or vomiting</p>
          </list-item>
        </list>
        <p>Interestingly, the authors noted that in 21 of 26 patients, the diagnosis of splenic infarct led to the diagnosis of a previously unrecognized underlying illness.</p>
      </sec>
      <sec id="article-29380.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Abdominal pain remains the leading chief complaint in patients diagnosed with a splenic infarct. Evaluation of patients who present with abdominal pain requires a broad differential approach.<xref ref-type="bibr" rid="article-29380.r6">[6]</xref><xref ref-type="bibr" rid="article-29380.r7">[7]</xref><xref ref-type="bibr" rid="article-29380.r8">[8]</xref></p>
        <p>Lab evaluation may help rule out other causes of abdominal pain. Elevated liver function tests, bilirubin or lipase, may suggest a hepatobiliary or pancreatic source for pain. Leukocytosis and elevated lactate dehydrogenase (LDH) may be found in splenic infarction. However, these results lack specificity to splenic infarct.</p>
        <p>Radiographic testing is required to&#x000a0;detect this rare illness. In the hyperacute phase of infarction, an abdominal CT scan performed with intravenous contrast is the imaging modality of choice in suspected splenic infarction. A splenic infarct appears as a wedge-shaped area of splenic tissue with the apex pointed toward the helium and the base of the splenic capsule. As the infarction matures, the affected tissue may normalize, liquefy, or become contracted or scarred.&#x000a0;Abdominal ultrasound has also been used to detect splenic infarction. Ultrasound findings of the hypoechoic wedge-shaped region of splenic tissue indicate infarction. Evolution of infarction may appear as hyperechoic with retraction of the splenic capsule.</p>
      </sec>
      <sec id="article-29380.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of splenic infarction is based primarily on the underlying causative disease state. Splenic infarction in the non-infectious setting may be treated with analgesics, hydration, anti-emetics, and other means of supportive care. Hospital admission may be required to&#x000a0;provide supportive treatment, monitoring, and further diagnostic testing if the&#x000a0;underlying cause is not established. In patients with sickle cell hemoglobinopathies, treatment to correct hypoxia and acidosis may be required. In the case of septic emboli, patients may require intravenous antibiotics and further cardiac evaluation. In patients with an underlying hematologic disease or autoimmune disease, consultation with hematology, oncology, or rheumatology may be indicated. Abdominal pain due to uncomplicated cases of splenic infarction resolves without intervention in 7 to 14 days.<xref ref-type="bibr" rid="article-29380.r2">[2]</xref><xref ref-type="bibr" rid="article-29380.r9">[9]</xref><xref ref-type="bibr" rid="article-29380.r10">[10]</xref></p>
        <p>In the case of traumatic splenic injury, abnormal vasculature, or hemodynamic instability, a surgical evaluation may be required. Dangerous complications of splenic infarction include pseudocyst formation, abscess, hemorrhage,&#x000a0;splenic rupture, and aneurysm. In some instances, the infarcted splenic tissue may become infected and lead to abscess formation. Infarcted tissue may also&#x000a0;undergo a hemorrhagic transformation. These complications warrant emergent surgical consultation.&#x000a0;</p>
      </sec>
      <sec id="article-29380.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Acute leukemias</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Cardioembolic origin</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Cytomegalovirus</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hemoglobinopathy</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Infectious mononucleosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Infective endocarditis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Myelodysplastic syndromes</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Myelofibrosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Wandering spleen</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29380.s10" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Splenic infarcts are a rare cause of abdominal pain. The patients often present to the emergency department physician, primary care provider, nurse practitioner, or internist. The pathology is easily identified with imaging studies, but its management requires an interprofessional team.</p>
        <p>Treatment of splenic infarction is based primarily on the underlying causative disease state. Splenic infarction in the non-infectious setting may be treated with analgesics, hydration, anti-emetics, and other means of supportive care. In the case of traumatic splenic injury, abnormal vasculature, or hemodynamic instability, a surgical evaluation may be required. Dangerous complications of splenic infarction include pseudocyst formation, abscess, hemorrhage,&#x000a0;splenic rupture, and aneurysm. In some instances, the infarcted splenic tissue may become infected and lead to abscess formation. Infarcted tissue may also&#x000a0;undergo a hemorrhagic transformation. These complications warrant emergent surgical consultation.&#x000a0;</p>
        <p>In patients undergoing surgery, it is important to ensure that the patient does get vaccinated against encapsulated organisms. For traumatic cases, the outlook is excellent, but in patients with sickle cell disease or a chronic hematological disorder, repeated episodes may occur.<xref ref-type="bibr" rid="article-29380.r11">[11]</xref></p>
      </sec>
      <sec id="article-29380.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29380&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29380">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/gut-health/splenic-infarcts/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29380">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29380/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29380">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29380.s12">
        <title>References</title>
        <ref id="article-29380.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kato</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gleeson</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Splenic necrosis requiring ultrasound-guided drainage following meningococcal septicaemia.</article-title>
            <source>Oxf Med Case Reports</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>2019</volume>
            <issue>3</issue>
            <fpage>omz020</fpage>
            <pub-id pub-id-type="pmid">30949357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29380.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mamoun</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Houda</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>[Splenic infarction revealing infectious endocarditis in a pregnant woman: about a case and brief literature review].</article-title>
            <source>Pan Afr Med J</source>
            <year>2018</year>
            <volume>30</volume>
            <fpage>184</fpage>
            <pub-id pub-id-type="pmid">30455813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29380.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niccoli Asabella</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Altini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nappi</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Lavelli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Marzullo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Loiodice</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rubini</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Sickle cell diseases: What can nuclear medicine offer?</article-title>
            <source>Hell J Nucl Med</source>
            <year>2019</year>
            <season>Jan-Apr</season>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <page-range>2-3</page-range>
            <pub-id pub-id-type="pmid">30843001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29380.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wand</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Tayer-Shifman</surname>
                <given-names>OE</given-names>
              </name>
              <name>
                <surname>Khoury</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hershko</surname>
                <given-names>AY</given-names>
              </name>
            </person-group>
            <article-title>A practical approach to infarction of the spleen as a rare manifestation of multiple common diseases.</article-title>
            <source>Ann Med</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>50</volume>
            <issue>6</issue>
            <fpage>494</fpage>
            <page-range>494-500</page-range>
            <pub-id pub-id-type="pmid">29929401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29380.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smalls</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Obirieze</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ehanire</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>The impact of coagulopathy on traumatic splenic injuries.</article-title>
            <source>Am J Surg</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>210</volume>
            <issue>4</issue>
            <fpage>724</fpage>
            <page-range>724-9</page-range>
            <pub-id pub-id-type="pmid">26384795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29380.r6">
          <label>6</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bender</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Carlberg</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Sickle Cell Disease</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2003</year>
            <month>9</month>
            <day>15</day>
            <pub-id pub-id-type="pmid">20301551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29380.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>el Barzouhi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Buren</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Nieuwkoop</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Renal and Splenic Infarction in a Patient with Familial Hypercholesterolemia and Previous Cerebral Infarction.</article-title>
            <source>Am J Case Rep</source>
            <year>2018</year>
            <month>Dec</month>
            <day>10</day>
            <volume>19</volume>
            <fpage>1463</fpage>
            <page-range>1463-1466</page-range>
            <pub-id pub-id-type="pmid">30531677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29380.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nofal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zeinali</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sawaf</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Splenic infarction induced by epstein-barr virus infection in a patient with sickle cell trait.</article-title>
            <source>J Paediatr Child Health</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>249</fpage>
            <page-range>249-251</page-range>
            <pub-id pub-id-type="pmid">30746887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29380.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pereda</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Isaac</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jayakumar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>Massive Splenic Infarction in a Child With Sickle Cell Disease on Chronic Transfusion Therapy.</article-title>
            <source>J Pediatr Hematol Oncol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>41</volume>
            <issue>2</issue>
            <fpage>e79</fpage>
            <page-range>e79-e82</page-range>
            <pub-id pub-id-type="pmid">30499910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29380.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blackwood</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Binder</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Unusual Complications From Babesia Infection: Splenic Infarction and Splenic Rupture in Two Separate Patients.</article-title>
            <source>J Emerg Med</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>55</volume>
            <issue>5</issue>
            <fpage>e113</fpage>
            <page-range>e113-e117</page-range>
            <pub-id pub-id-type="pmid">30253953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29380.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fernando</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mendis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Upasena</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Moratuwagama</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Splenic Syndrome in a Young Man at High Altitude with Undetected Sickle Cell Trait.</article-title>
            <source>J Patient Exp</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <page-range>153-155</page-range>
            <pub-id pub-id-type="pmid">29978033</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
